SCHEMBL1314345

SCHEMBL1314345

CCOC(=O)c1cc2cc(-c3nccc(C(=O)NCc4ccc(OC)cc4OC)n3)ccc2[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 1/20 0.53
NPC1 O15118 1/20 0.53
LMNA P02545 1/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MMP13 P45452 9/20 0.51
MMP14 P50281 5/20 0.48
MMP2 P08253 4/20 0.48
AURKA O14965 1/20 0.48
MMP10 P09238 1/20 0.48
MMP9 P14780 1/20 0.48
PRKACA P17612 1/20 0.48
DRD5 P21918 1/20 0.48
MAPKAPK2 P49137 1/20 0.48
PRKAA1 Q13131 1/20 0.48
TSHR P16473 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1314480 0.91 ALDH1A1 (0.56) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL1314275 0.86 ALDH1A1 (0.54) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL1316578 0.83 KDM4E (0.54) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL1314329 0.81 KDM4E (0.55) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL1313687 0.80 KDM4E (0.54) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL1315144 0.79 MMP13 (0.59) MMP13MMP14MMP2AURKAMMP10
SCHEMBL1314348 0.76 RAB9A (0.52) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL7920046 0.74 TSHR (0.46) ALDH1A1LMNATSHRNPSR1MAPT
SCHEMBL12122261 0.73 MAPT (0.49) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL1315170 0.73 MMP13 (0.79) MMP13MMP14MMP2AURKAMMP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785489-B2 Heteroaryl substituted indole compounds useful as MMP-13 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-22 US disclosed
US-8785489-B2 Heteroaryl substituted indole compounds useful as MMP-13 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-22 US disclosed
US-20110275631-A1 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-10 US disclosed
US-20110275631-A1 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-10 US disclosed
EP-2340243-A1 HETEROARYL SUBSTITUTED INDOLE COMPOUNDS USEFUL AS MMP-13 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2011-07-06 EP disclosed
WO-2010045188-A1 HETEROARYL SUBSTITUTED INDOLE COMPOUNDS USEFUL AS MMP-13 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-22 WO disclosed
WO-2010045188-A1 HETEROARYL SUBSTITUTED INDOLE COMPOUNDS USEFUL AS MMP-13 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275631-A1 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors MMP13, MMP3, MMP11 ALDH1A1 311/4885KDM4E 2155/4885NPC1 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.